Search Results 791-800 of 17098 for treatment resistant depression
This especially includes medicines used to treat depression, including citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, olanzapine, paroxetine ...
Participation eligibility · Diagnosis of CD30+ classical Hodgkin lymphoma reconfirmed by histopathology. · Relapsed or refractory disease after standard therapy ...
Allen, M.D.. Psychiatrist. Rochester, MN. Areas of focus: Electroconvulsive therapy, Delirium, Neurocognitive disorder, Depression, Anxiety disorder, Bipolar ...
About this study. The purpose of this study is to see how well study drug works at treating people with fungal diseases that are refractory to or intolerant of ...
The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
Diagnosis & treatmentCare at Mayo Clinic. Oct. 14, 2023. Print. Living ... drug-resistant epilepsy April 07, 2025, 02:16 p.m. CDT; (VIDEO) When seizures ...
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma. Print details. Share; Facebook · Twitter.
Kids and screen time / transcranial magnetic stimulation therapy for depression / oral cancer reconstruction: Mayo Clinic Radio. As summer vacation rolls on ...
The purpose of Phase I of this study is to evaluate the safety and tolerability of CTX-712 in patients with relapsed/refractory (R/R) acute myeloid leukemia ( ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.